Echo Therapeutics

Curated by Signal

Wearable devices and app for blood glucose monitoring and behavior modification for improving disease condition

Overview

Echo Therapeutics provides a glucose sensor for continuous and non-invasive glucose monitoring, which is paired with a mobile application and a wearable for data display. Their technology is backed by a skin preparation device, which exfoliates dead skin, that is further used in glucose sensing. Patients get real-time feedback for behavior modifications, specifically food intake, in order to improve their disease condition. Also developing an API for developers to build their own apps for Echo's glucose monitoring system. Partnered with MTIA and Handok. Went public in 2011.

Key facts

Founded: 1989
Headquarters: Franklin, United States
Stage: Sign up to view
Industry: High Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More High Technology companies

Bots Alive
Develops an AI based platform that provides autonomy to Hexbug robots
High TechnologyAustin, United States
Lifelink Systems
AI-based patient engagement tool for healthcare professionals
High TechnologySan Francisco, United States
GENBA
Provider of an AI and voice-enabled maintenance assisting platform for workforces
High TechnologySeattle, United States

About Echo Therapeutics

What does Echo Therapeutics do?

Echo Therapeutics provides a glucose sensor for continuous and non-invasive glucose monitoring, which is paired with a mobile application and a wearable for data display.

Where is Echo Therapeutics headquartered?

Echo Therapeutics is headquartered in Franklin, United States.

When was Echo Therapeutics founded?

Echo Therapeutics was founded in 1989.

Which sector is Echo Therapeutics in?

Echo Therapeutics operates in High Technology.

Who are Echo Therapeutics's competitors?

Companies similar to Echo Therapeutics include Bots Alive, Lifelink Systems, and GENBA.